Figure 2 | Scientific Reports

Figure 2

From: High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals

Figure 2

Association between fluoroquinolone MIC levels and exoU+/exoU− isolates. Only significant differences are reported. (a) Differences in the levofloxacin MIC levels between exoU+ and exoU− isolates. S: Susceptible (MIC ≤ 2 mg/L; p = 0.001596); I: Intermediate (MIC of 4 mg/L); LR: Low Resistance Levels (MIC of 8–16 mg/L); MR: Moderate Resistance Levels (MIC of 32–64 mg/L); HR: High Resistance Levels (MIC > 128 mg/L; p = 0.002818). (b) Differences in the ofloxacin MIC levels between exoU+ and exoU− isolates. S: Susceptible (MIC ≤ 2 µg/ml; p = 0.003488); I: Intermediate (MIC of 4 µg/ml); LR: Low Resistance Levels (MIC of 8–16 mg/L); MR: Moderate Resistance Levels (MIC of 32–64 mg/L); HR: High Resistance Levels (MIC > 128 mg/L; p = 0.004902). (c) Differences in the ciprofloxacin MIC levels between exoU+ and exoU− isolates. S: Susceptible (MIC ≤ 1 mg/L; p = 0.000859); I: Intermediate (MIC of 2 mg/L); LR: Low Resistance Levels (MIC of 4–8 mg/L); MR: Moderate Resistance Levels (MIC of 16–32 mg/L); HR: High Resistance Levels (MIC > 64 mg/L; p = 0.000191).

Back to article page